Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.32M Sell
6,409
-44
-0.7% -$15.1K 1.39% 16
2026
Q1
$2.27M Sell
6,453
-152
-2% -$54.2K 1.5% 15
2025
Q4
$2.16M Sell
6,605
-104
-2% -$33K 1.46% 15
2025
Q3
$1.89M Buy
6,709
+74
+1% +$21.5K 1.31% 16
2025
Q2
$1.85M Sell
6,635
-56
-0.8% -$15.9K 1.39% 18
2025
Q1
$2.08M Sell
6,691
-104
-2% -$30.7K 1.71% 14
2024
Q4
$1.77M Buy
+6,795
New +$2.02M 1.42% 18

Other funds holding AMGN

MFA Wealth Services's AMGN Position: Q2 2026 in Review

MFA Wealth Services reduced its Amgen (AMGN) stake by 0.68% in Q2 2026, selling an estimated $15.1K and leaving 6,409 shares worth $2.32M. The position accounts for 1.39% of the portfolio, ranked #16.

MFA Wealth Services first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • MFA Wealth Services held 6,409 shares of Amgen worth $2.32M as of Q2 2026.
  • MFA Wealth Services sold 44 Amgen shares in Q2 2026, an estimated $15.1K.
  • Amgen made up 1.39% of MFA Wealth Services's portfolio in Q2 2026, its #16 holding.
  • MFA Wealth Services first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on MFA Wealth Services's 13F filing for Q2 2026, filed 22 Jul 2026.